CollPlant Biotechnologies Ltd (CLGN) Form 6-K — Aug 31, 2026
CollPlant Biotechnologies signed a Share Purchase Agreement on August 29, 2026 to acquire 100% of LightSolver Ltd, an Israeli photonics company, with closing expected within the week. LightSolver CEO and co-founder Dr. Ruti Ben Shlomi joins CollPlant's board, and both key executives are committed to at least 36 months of continued service post-closing. The all-stock consideration includes 3,734,476 shares equal to 19.7% of pre-deal shares outstanding, pre-funded warrants on 6,134,363 shares, and milestone warrants on 224,078,345 shares across three tranches, all at a $0.00001 exercise price.
Key figures
- Closing Shares
- 3734476
- Finder Warrant Shares
- 2000000
- Rollover Option Shares
- 2261966
- Finder Warrant Term Years
- 5
- Pre Funded Warrant Shares
- 6134363
- Key Person Retention Months
- 36
- Milestone Warrant Shares Total
- 224078345
- Finder Warrant Exercise Price Usd
- 0.36
- Milestone Warrant Series1 Shares
- 24746310
- Milestone Warrant Series2 Shares
- 96295669
- Milestone Warrant Series3 Shares
- 103036366
- Net Cash Transfer To Light Solver Usd
- 5000000
- Warrant Exercise Price Per Share Usd
- 0.00001
- Outstanding Safe Purchase Amount Usd
- 2000000
- Contingent Pre Funded Warrant Max Shares
- 4724184
- Resale Registration Filing Deadline Days
- 75
- Advisor Acquisition Shares Rodman Renshaw
- 186724
- Contingent Pre Funded Warrant Trigger Per Usd
- 6250000
- Closing Shares Percent Of Pre Deal Outstanding
- 19.7%
- Advisor Milestone Warrant Shares Rodman Renshaw
- 11203916
- Resale Registration Effectiveness Deadline Days
- 180
- Asset Monetization Net Proceeds To Officers Percent
- 20%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.